Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions, What's New from the U.S. Preventive Services Task Force (USPSTF)

QualityTool

Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions, What's New from the U.S. Preventive Services Task Force (USPSTF)

Description

This fact sheet presents highlights of the U.S. Preventive Services Task Force (USPSTF) recommendations on hormone replacement therapy (HRT) for the primary prevention of chronic conditions. The USPSTF systematically reviews the evidence of effectiveness of a wide range of clinical preventive services—including screening, counseling, and chemoprevention (the use of medication to prevent diseases)—to develop recommendations for preventive care in the primary care setting.

Some health topics discussed include:

  • Does the USPSTF recommend HRT for women after menopause?
  • How does this USPSTF recommendation differ from its previous recommendation?
  • Why did the USPSTF release a new recommendation on HRT?
  • How can doctors help women decide whether to take HRT?

Developer:

U.S. Preventive Services Task Force (USPSTF)

Funding Sources:

Agency for Healthcare Research and Quality

History

Release Date: 2002
Original Summary: February 2004
Last Updated: 04/04/12

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.